AbbVie Inc. v. Novartis Vaccines and Diagnostics, Inc. et al

Filing 56

STIPULATION AND ORDER re 55 REGARDING BRIEFING SCHEDULE AND MOTION HEARING filed by Novartis Vaccines and Diagnostics, Inc. REGARDING BRIEFING SCHEDULE AND MOTION HEARING, 48 MOTION to Compel Arbitration and To Stay . Responses due by 7/7/2017. Replies due by 7/21/2017. Motion Hearing set for 8/17/2017 01:30 PM in Courtroom 5, 17th Floor, San Francisco before Edward M. Chen. Case Management Statement due by 11/9/2017. Initial Case Management Conference reset for 11/16/2017 09:30 AM in Courtroom 5, 17th Floor, San Francisco. Signed by Judge Edward M. Chen on 6/8/17. (bpfS, COURT STAFF) (Filed on 6/8/2017)

1
2
3
4
5
6
7
8
9

11
12
ATTORNEYS AT LAW

M C D ERMOTT W ILL & E MERY LLP

10

THOMAS P. STEINDLER (Pro Hac Vice)
[e-mail]
MICHAEL V. O’SHAUGHNESSY (Pro Hac Vice)
[e-mail]
MCDERMOTT WILL & EMERY LLP
500 N. Capitol St., N.W.
Washington, DC 20001
Tel: [phone]
Fax: [phone]

MICHAEL A. MORIN (Pro Hac Vice)
[e-mail]
DAVID P. FRAZIER (Pro Hac Vice)
[e-mail]
ELISSA N. KNOFF (SBN: 309497)
[e-mail]
LATHAM & WATKINS LLP
555 Eleventh Street, NW, Suite 1000
Washington, D.C. 20004
Tel: [phone]
Fax: [phone]

WILLIAM G. GAEDE III (SBN: 136184)
[e-mail]
MCDERMOTT WILL & EMERY LLP
275 Middlefield Road, Suite 100
Menlo Park, CA 94025
Tel: [phone]
Fax: [phone]

GREGORY K. SOBOLSKI (SBN 267428)
[e-mail]
LATHAM & WATKINS LLP
505 Montgomery St., Suite 2000
San Francisco, CA 94111
Tel: [phone]
Fax: [phone]

NICOLE CLOUSE (Pro Hac Vice)
[e-mail]
MCDERMOTT WILL & EMERY LLP
28 State Street
Boston, MA 02109
Tel: [phone]
Fax: [phone]

Attorneys for AbbVie Inc.
ANDREA MEGHROUNI-BROWN
(SBN 14823)
[e-mail]
GRIFOLS DIAGNOSTIC
SOLUTIONS INC.
4560 Horton Street
Emeryville, CA 94608
Tel: [phone]
Fax: [phone]

See attached list of co-counsel.

13
14
15

Attorney for Grifols Worldwide
Operations Ltd.

16
17

Attorneys for Novartis Vaccines and Diagnostics, Inc.

18

IN THE UNITED STATES DISTRICT COURT

19

IN AND FOR THE NORTHERN DISTRICT OF CALIFORNIA

20

SAN FRANCISCO DIVISION

21
22
23
24
25

ABBVIE INC.,

Case No. 3:17-CV-01815 EMC
Plaintiff,

v.
NOVARTIS VACCINES AND
DIAGNOSTICS, INC. and GRIFOLS
WORLDWIDE OPERATIONS LTD.,
Defendants.

STIPULATION & [PROPOSED]
ORDER TO MODIFY BRIEFING
SCHEDULE AND HEARING DATE
FOR MOTION TO COMPEL
ARBITRATION AND TO STAY

26
27
28
STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC

1
2
3
4
5
6
7
8
9

Additional co-counsel:
SHERMAN KAHN (SBN: 168924)
[e-mail]
MAURIEL KAPOUYTIAN WOODS LLP
15 W. 26th Street, 7th Floor
New York, NY 10010
Tel: [phone]
Fax: [phone]
JASON R. BARTLETT (SBN: 214530)
[e-mail]
MARC J. PERNICK (SBN: 160591)
[e-mail]
MAURIEL KAPOUYTIAN WOODS LLP
275 Battery Street, Suite 480
San Francisco, CA 94111
Tel: [phone]
Fax: [phone]

11
12
ATTORNEYS AT LAW

M C D ERMOTT W ILL & E MERY LLP

10

13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-1-

STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC

1

Plaintiff AbbVie Inc. (“AbbVie”), Defendant Novartis Vaccines and Diagnostics, Inc.

2

(“Novartis”) and Defendant Grifols Worldwide Operations Ltd. (“Grifols”) file this stipulated

3

request and respectfully ask the Court to modify the briefing schedule for Defendant Novartis’s

4

Motion to Compel Arbitration and to Stay (“Motion to Compel Arbitration”). As grounds, the

5

parties state as follows:

6

On June 5, 2017, Novartis filed its Motion to Compel Arbitration (ECF No. 48) in this

7

case. In view of the schedules of counsel and with consideration to the Court’s schedule over the

8

coming months, the undersigned counsel met, conferred and agreed to extend the briefing

9

schedule and hearing date as follows:

Event

6/19/2017

7/7/2017

6/26/2017

7/21/2017

Motion Hearing

13

New Date

Replies Due

12

Original Date

Responses Due

11
ATTORNEYS AT LAW

M C D ERMOTT W ILL & E MERY LLP

10

7/13/2017, 1:30pm

8/17/2017, 1:30pm

14
15
16
17
18
19
20
21
22
23
24

In addition, on June 5, 2017, the parties also filed a stipulated request to stay the
proceedings in this case pending resolution of the Motion To Compel Arbitration and to Stay,
which the Court granted on June 6, 2017. (ECF No. 53) (“Pursuant to Stipulation, all scheduling
requirements are stayed until the Court issues its ruling on Novartis’ Motion To Compel
Arbitration and to Stay”). On that same date, however, a Clerk’s Notice was entered stating that
the Case Management Conference is reset to August 24, 2017 with the Case Management
Statement due on August 17, 2017. (ECF No. 54) Given the Court’s June 6, 2017 Order staying
“all scheduling requirements” in this case “until the Court issues its ruling on Novartis’ Motion
To Compel Arbitration and to Stay,” the parties respectfully request that the June 6, 2017 Clerk’s
Notice setting the Case Management Conference be vacated.

25
26

Grifols respectfully continues to reserve its right to challenge service of process in this
case.

27
28
-2-

STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC

WHEREFORE, the parties respectfully request that, for good cause shown, the Court
1

grant this stipulated request.

2
3
4

Dated: June 8, 2017

Respectfully submitted,

5
6
7
8

MCDERMOTT WILL & EMERY LLP
By:

/s/ Thomas P. Steindler
Thomas P. Steindler

Attorneys for Novartis Vaccines and Diagnostics, Inc.

9

11
12
ATTORNEYS AT LAW

M C D ERMOTT W ILL & E MERY LLP

10

13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-3-

STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC

LATHAM & WATKINS LLP

1
2
3

By:

/s/ Gregory K. Sobolski
Gregory K. Sobolski

Attorneys for AbbVie Inc.

4
5
6
7

/s/ Andrea Meghrouni-Brown
Andrea Meghrouni-Brown
Attorney for Grifols Worldwide Operations Ltd.

8
9

11
12
ATTORNEYS AT LAW

M C D ERMOTT W ILL & E MERY LLP

10

13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-4-

STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC

1

SIGNATURE ATTESTATION

2
3
4
5

Pursuant to General Order 45.X(B), I hereby attest that concurrence has been obtained
from Gregory K. Sobolski and Andrea Meghrouni-Brown indicated by the “conformed”
signatures (/s/) within this e-filed document.
/s/ Thomas P. Steindler
Thomas P. Steindler

6
7
8
9

11
12
ATTORNEYS AT LAW

M C D ERMOTT W ILL & E MERY LLP

10

13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-5-

STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC

1

[PROPOSED] ORDER

2
3

Pursuant to Stipulation, the briefing schedule for Novartis’ Motion to Compel Arbitration
and to Stay has been modified as follows:

4
Event

6/19/2017

7/7/2017

6/26/2017

7/21/2017

Motion Hearing

7

New Date

Replies Due

6

Original Date

Responses Due

5

7/13/2017, 1:30pm

8/17/2017, 1:30pm

8

9:30 a.m. A joint CMC statement
shall be filed by 11/9/17.

IT IS SO ORDERED.

Date:
14

ard M.

NO

17

RT

DM_US 82443209-5.085448.0181

dw
Judge E

H

ER

20

R NIA

IT IS
DIFIED
AS MO

Chen

FO

16

19

S DISTRICT
TE
C
TA

The Honorable Edward M. Chen
ED
United States ORDER
O District Judge
S

15

18

S

6/8/17

13

UNIT
ED

ATTORNEYS AT LAW

12

LI

11

Management Conference is hereby VACATED. reset from 8/24/17 to 11/16/17 at

RT
U
O

M C D ERMOTT W ILL & E MERY LLP

10

In addition, the Clerk’s Notice dated June 6, 2017 (ECF No. 54) setting a date for the Case

A

9

N

F
D IS T IC T O
R

C

21
22
23
24
25
26
27
28
-6-

STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC